Phoebe’s pilot program for heart attack detection

Clinical trial agreement reached between health system and HeartBeam

ALBANY, GA – Albany’s Phoebe Putney hospital will be the first in the nation to study a new software’s effectiveness in detecting heart attacks of emergency patients.

Monday, Phoebe revealed it has entered a business associate and clinical trial agreement with HeartBeam, Inc.

Phoebe and HeartBeam will conduct a pilot study designed to evaluate the company’s emergency department myocardial infarction software products.

” We are excited to begin this study of electrocardiograms on chest pain patients previously treated in our emergency center to determine the technology’s effectiveness in rapidly detecting a heart attack. Chest pain is the second most common reason for an ER visit, with high costs associated to the visits. HeartBeam’s software is a promising solution for more accurate MI detection,” says Doug Gregory, Phoebe’s Vice-President of Heart & Vascular Services.

The HeartBeam ED MI software product utilizes proprietary 3D technology to help emergency physicians achieve a more accurate and timely heart attack detection.

Under the terms of the agreements, Phoebe will conduct a retrospective study in its main emergency center, using ECGs from previous patients who came to the ER because of chest pain.

Results from the HeartBeam algorithm will be compared with the treating physician’s interpretation and the diagnostic suggestion from the ECG to determine the accuracy of the software.

The study is planned to begin March of 2022.

The results could assist HeartBeam in gaining product approval from the Food & Drug Administration.